These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 2574193)

  • 21. Long-term anxiolytic therapy: the issue of drug withdrawal.
    Lader M
    J Clin Psychiatry; 1987 Dec; 48 Suppl():12-6. PubMed ID: 2891684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [alpha-beta L-aspartate magnesium in treatment of chronic benzodiazepine abuse: controlled and double-blind study versus placebo].
    Hantouche EG; Guelfi JD; Comet D
    Encephale; 1998; 24(5):469-79. PubMed ID: 9850822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symptom severity and quality of life after benzodiazepine withdrawal treatment in participants with complicated dependence.
    Vorma H; Naukkarinen H; Sarna S; Kuoppasalmi K
    Addict Behav; 2004 Aug; 29(6):1059-65. PubMed ID: 15236807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind, comparative study of cyamemazine vs. bromazepam in the benzodiazepine withdrawal syndrome.
    Lemoine P; Kermadi I; Garcia-Acosta S; Garay RP; Dib M
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):131-7. PubMed ID: 16243418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protracted tinnitus after discontinuation of long-term therapeutic use of benzodiazepines.
    Busto U; Fornazzari L; Naranjo CA
    J Clin Psychopharmacol; 1988 Oct; 8(5):359-62. PubMed ID: 2903182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of buspirone and placebo in relieving benzodiazepine withdrawal symptoms.
    Lader M; Olajide D
    J Clin Psychopharmacol; 1987 Feb; 7(1):11-5. PubMed ID: 2880872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Withdrawal and detoxification from benzodiazepine dependence: a potential role for clonazepam.
    Albeck JH
    J Clin Psychiatry; 1987 Oct; 48 Suppl():43-9. PubMed ID: 2889723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The withdrawal syndrome in benzodiazepine dependence and its management].
    Străulea AO; Chiriţă V
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):879-84. PubMed ID: 20191849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dependence on benzodiazepine and treatment of withdrawal syndrome].
    Sep-Kowalikowa B; Czucha M
    Psychiatr Pol; 2002; 36(6 Suppl):347-57. PubMed ID: 12647459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
    Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
    Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective review and assessment of benzodiazepines in the treatment of alcohol withdrawal in hospitalized patients.
    Hoey LL; Nahum A; Vance-Bryan K
    Pharmacotherapy; 1994; 14(5):572-8. PubMed ID: 7997390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S
    Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Benzodiazepines. Long-term prescription and withdrawal].
    Feline A; Le Goc I
    Encephale; 1983; 9(4 Suppl 2):103B-108B. PubMed ID: 6144504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Withdrawal phenomena in stepwise withdrawal of benzodiazepines].
    Soyka M; Steinberg R; Vollmer M
    Nervenarzt; 1988 Dec; 59(12):744-8. PubMed ID: 2905772
    [No Abstract]   [Full Text] [Related]  

  • 36. Risks and benefits of long-term benzodiazepine use.
    Uhlenhuth EH; DeWit H; Balter MB; Johanson CE; Mellinger GD
    J Clin Psychopharmacol; 1988 Jun; 8(3):161-7. PubMed ID: 2897976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physician Withdrawal Checklist (PWC-20).
    Rickels K; Garcia-Espana F; Mandos LA; Case GW
    J Clin Psychopharmacol; 2008 Aug; 28(4):447-51. PubMed ID: 18626273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utilizing CIWA-Ar to assess use of benzodiazepines in patients vulnerable to alcohol withdrawal syndrome.
    Nuss MA; Elnicki DM; Dunsworth TS; Makela EH
    W V Med J; 2004; 100(1):21-5. PubMed ID: 15119493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study.
    Gerra G; Zaimovic A; Giusti F; Moi G; Brewer C
    Addict Biol; 2002 Oct; 7(4):385-95. PubMed ID: 14578014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long term use and abuse of benzodiazepines.
    Carranza J
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Sep; 13(5):254-8. PubMed ID: 6108579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.